April 3, 2024

New guidelines regarding the use of hybrid closed loop technology

On December 19, 2023, the National Institute for Health and Care Excellence (NICE) released new guidelines regarding the use of hybrid closed loop technology (sometimes referred to as HCL or artificial pancreas) for patients with Type 1 diabetes.

NHS systems have been given five years starting from April 1, 2024, to fully implement the recommendations in the NICE guidelines.

During this time, clinical teams within the Suffolk and North East Essex Integrated Care System will be working together to identify those Type 1 diabetes patients with the greatest clinical need, and who meet the criteria stipulated in NICE TA 943, to ensure they are provided with this technology first, as recommended by NHS England’s national implementation strategy.

If you have Type 1 diabetes you will already be known to your specialist, so please be assured they will contact you in due course.

The full NICE guideline can be found here: Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes: Technology appraisal guidance [TA943]

The NHS England 5 year implementation strategy can be found here

Please see Q&A Nice Technology Appraisal Hybrid Closed Loop

< Back to news